INDIANAPOLIS, Nov. 18, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will participate in the Citi's 2025 Global Healthcare Conference on…
Initiative led by researchers in Australia and Japan aims to map cancer and immune interactions to advance precision oncology across…
– Partnership focuses on "kitted" tests in ex-U.S. markets, enabling accelerated access through a decentralized model – – Deal potentially…
New "click-to-sequence" platform lets researchers buy AI-designed antibody sequences online, using an AI system that learns from real lab results.…
– Initial commercial availability begins through an Early Experience Program with Penn Highlands Healthcare and Allegheny Health Network – SAN…
OCALA, Fla., Nov. 18, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today provided a…
Hyland expands its Enterprise Imaging portfolio with an agentic digital pathology platform that simplifies diagnostic workflows, enhances collaboration, and improves…
More than 20 years of financial and operational leadership in biopharma, including $170M+ in capital raised, global commercialization experience, and…
BRISBANE, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN) (“Day One” or the “Company”), a…
RESEARCH TRIANGLE PARK, N.C., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a…